Search General Info
Search Education
Search Partnering Companies

Victor Dzau, MD

Victor J. Dzau is the President of the US National Academy of Medicine and Vice Chair of the National Research Council. He is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University and the past CEO of Duke University Health System. Previously, Dr. Dzau was the Chairman of Medicine at Harvard’s Brigham and Women’s Hospital, as well as at Stanford University.

An internationally acclaimed scholar in the field of cardiovascular medicine and genetics, he helped create the science underlying the class of drugs known as ACE inhibitors, used globally to treat hypertension and heart failure. He is a pioneer in cardiovascular gene therapy. Dr Dzau have served on the board of directors of Genzyme, Medtronic and Alnylam. He is also world renowned for his leadership in global health and in developing major national and international collaborative health policy initiatives. Leading the National Academy of Medicine, he has launched important initiatives such as the Global Health Risk Framework and Human Gene Editing . Importantly, the NAM is launching a Grand Challenge in Climate Change and Human Health & Equity to activate the biomedical community, educate the public about climate and health, driving changes through research, innovation and policy, take on the bold action of decarbonizing the health care sector.